(Q30836702)

English

Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial (English)

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

0 references

1 reference

based on heuristic

inferred from title

Michael Platten

8

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Stefan M. Pfister

11

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Volker Hovestadt

object named as

Volker Hovestadt

3

0 references

17

object named as

Michael Weller

1 reference

Europe PubMed Central

16 October 2017

PMC publication ID

18

object named as

Wolfgang Wick

1 reference

Europe PubMed Central

16 October 2017

PMC publication ID

Guido Reifenberger

14

object named as

Guido Reifenberger

1 reference

Europe PubMed Central

16 October 2017

PMC publication ID

2

object named as

David Capper

1 reference

Europe PubMed Central

16 October 2017

PMC publication ID

Richard Meyermann

13

object named as

Richard Meyermann

1 reference

Europe PubMed Central

16 October 2017

PMC publication ID

4

object named as

Martin Sill

1 reference

Europe PubMed Central

16 October 2017

PMC publication ID

David T. W. Jones

5

object named as

David T W Jones

2 references

Europe PubMed Central

PMC publication ID

16 October 2017

ORCID Public Data File 2021

12

object named as

Otmar D Wiestler

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

10

object named as

Kathy Keyvani

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

7

object named as

Joerg Felsberg

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

author name string

Christian Hartmann

6

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Wolfgang Feiden

9

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Thorsten Pietsch

15

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

15 July 2014

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

16

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

12

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

1630-1638

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Neuro-oncology in 2013: improving outcome in newly diagnosed malignant glioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

The integrated landscape of driver genomic alterations in glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

Molecular neuro-oncology in clinical practice: a new horizon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

IDH testing in diagnostic neuropathology: review and practical guideline article invited by the Euro-CNS research committee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

pROC: an open-source package for R and S+ to analyze and compare ROC curves

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

Gone FISHing: clinical lessons learned in brain tumor molecular diagnostics over the last decade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

IDH1 and IDH2 mutations in gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

An integrated genomic analysis of human glioblastoma multiforme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

Validation of real-time methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in glioma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

Long-term survival with glioblastoma multiforme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

21 June 2018

All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2.

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU138

21 January 2018

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU138

21 January 2018

Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU138

21 January 2018

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU138

21 January 2018

Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU138

21 January 2018

Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU138

21 January 2018

Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system.

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU138

21 January 2018

Multiplex ligation-dependent probe amplification for the detection of 1p and 19q chromosomal loss in oligodendroglial tumors.

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU138

21 January 2018

Allelic status of 1p and 19q in oligodendrogliomas and glioblastomas: multiplex ligation-dependent probe amplification versus loss of heterozygosity.

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU138

21 January 2018

MGMT CpG island is invariably methylated in adult astrocytic and oligodendroglial tumors with IDH1 or IDH2 mutations.

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU138

21 January 2018

IDH testing in diagnostic neuropathology: review and practical guideline article invited by the Euro-CNS research committee

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU138

21 January 2018

Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232086

25 November 2018

Identifiers

10.1093/NEUONC/NOU138

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30836702&oldid=1859577669"